Evidence map›Paper›PMID 40047227›Full record

ArticleEuropean journal of translational myology2025

Padua Days on Muscle and Mobility Medicine, March 25-29, 2025, Hotel Petrarca, Euganean Thermae, Italy: Program and Abstracts.

Barbara Ravara, Paolo Gargiulo, David Hood, Lars Larsson, Christiaan Leeuwenburgh, Maria Chiara Maccarone, Stefano Masiero, Philippe Perrin, Amber Pond, Riccardo Rosati and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of translational myology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Gifts for EJTM authors and readers and for PDM3 participants.European journal of translational myology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Barbara RavaraDepartment of Biomedical Sciences, University of Padova, Padua, Italy; Interdepartmental Research Centre of Myology, University of Padova, Padua Italy; A&C M-Carraro Foundation for Translational Myology, Padua. barbara.ravara@unipd.it.
Paolo GargiuloInstitute of Biomedical and Neural Engineering, Reykjavik University, Reykjavik, Iceland; Landspitali, University Hospital of Iceland, Reykjavik. paolo@ru.is.
David HoodMuscle Health Research Centre, School of Kinesiology and Health Science, York University, Toronto. dhood@yorku.ca.
Lars LarssonDepartment of Clinical Sciences, SLU, Uppsala. lars.larsson@slu.se.
Christiaan LeeuwenburghDepartment of Physiology and Aging, College of Medicine, University of Florida, FL. cleeuwen@ufl.edu.
Maria Chiara MaccaroneDepartment of Neuroscience, Rehabilitation Unit, University of Padova. mariachiara.maccarone@phd.unipd.it.
Stefano MasieroInterdepartmental Research Centre of Myology, University of Padova, Padua Italy; Department of Neuroscience, Rehabilitation Unit, University of Padova, Italy; School of Physical Medicine and Rehabilitation, Department of Neuroscience, University of Padova, Padua. stef.masiero@unipd.it.
Philippe PerrinDevelopment, Adaptation and Handicap, Faculty of Medicine, University of Lorraine, Vandoeuvre-lès-Nancy. philippe.perrin@univ-lorraine.fr.
Amber PondAnatomy Department, Southern Illinois University School of Medicine, Carbondale, IL. apond@siumed.edu.
Riccardo RosatiDepartment of Biomedical Surgical and Dental Sciences, University of Milan. riccardo@riccardorosati.eu.
Piera SmeriglioSorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, Paris. p.smeriglio@institut-myologie.org.
Lee SweeneyMyology Institute, University of Florida, Gainesville, Florida. lsweeney@ufl.edu.
Daniela TavianLaboratory of Cellular Biochemistry and Molecular Biology, CRIBENS, Università Cattolica del Sacro Cuore, Milan. daniela.tavian@unicatt.it.
Gerd Fabian VolkENT-Department, Facial-Nerve-Center and Center of Rare Diseases, Jena University Hospital, Jena. fabian.volk@med.uni-jena.de.
Ugo CarraroDepartment of Biomedical Sciences, University of Padova, Padua, Italy; Interdepartmental Research Centre of Myology, University of Padova, Padua Italy; A&C M-Carraro Foundation for Translational Myology, Padua, Italy; School of Physical Medicine and Rehabilitation, Department of Neuroscience, University of Padova, Padua. ugo.carraro@unipd.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medium-sized scientific conferences held in hotels large enough to accommodate all participants increase opportunities for constructive discussion during breaks, and for evenings that bring together young and senior experts of basic sciences and clinical specialties. Time for group discussions offer opportunities for new collaborations and for jobs for young researchers. Since 1991 the Padova Muscle Days have offered collaborative opportunities that have matured into innovative multidisciplinary results to the point that it came naturally for us to underline it with a neologism now included in the title of the 2025 event: "Mobility Medicine". It is a discipline which developed naturally when we brought together fragmented areas of knowledge into one meeting. The Padua Days on Muscle and Mobility Medicine 2025 (2025Pdm3) will be hosted at the Hotel Petrarca, Euganean Thermae (Padua, Italy) from 25 to 29 March 2025. The list of unique sessions within the included program and the following Collection of Abstracts testify that it is possible to organize valid countermeasures to the inevitable tendencies towards hyper-specialization that the explosive increase in scientific progress brings. The European Journal of Translational Myology and Mobility Medicine (Ejtm3) will accept typescripts on results presented at the 2025Pdm3. Furthermore, an additional option for publication of full original Articles or Reviews is the Special "New Trends in Musculoskeletal Imaging" of the MDPI Journal Diagnostics, because diagnosis is essential to manage and follow-up neuro- metabolic- muscular- disorder and the decay of performances in aging. We hope that many will share our dreams and we make them come true at the 2025 Pdm3 Conference.

Identifiers

PMID40047227
PMCPMC12042174

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.